Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) and radiotherapy (RT) are widely used for patients with brain metastasis (BM). To evaluate markers for treatment response and find a treatment concept which has the best outcome effects, we analyzed data of 93 patients with BM from different cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Trommer, Maike, Adams, Anne, Celik, Eren, Fan, Jiaqi, Funken, Dominik, Herter, Jan M., Linde, Philipp, Morgenthaler, Janis, Wegen, Simone, Mauch, Cornelia, Franklin, Cindy, Galldiks, Norbert, Werner, Jan-Michael, Kocher, Martin, Rueß, Daniel, Ruge, Maximilian, Meißner, Anna-Katharina, Baues, Christian, Marnitz, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909717/
https://www.ncbi.nlm.nih.gov/pubmed/35267546
http://dx.doi.org/10.3390/cancers14051240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909717/
https://www.ncbi.nlm.nih.gov/pubmed/35267546
http://dx.doi.org/10.3390/cancers14051240

Ejemplares similares